|
Year ended
31 March 2006
|
Year ended
31 March 2007
|
Year ended
31 March 2008
|
Revenue
|
¥1.6 billion
|
¥4.0 billion
|
¥7.0 billion
|
Pre-tax profit
|
¥1.2 billion
|
¥2.8 billion
|
¥4.9 billion
|
Profit after tax
|
¥0.7 billion
|
¥1.6 billion
|
¥2.9 billion
|
|
|
|
|
No. of clients trading in March
|
4,154
|
8,355
|
11,747
|
No. of lots traded in March
|
90,254
|
150,544
|
283,797
|
IG will host a conference call for analysts and investors today, 24 September 2008, at 9.00 am (London). Interested parties can listen to the conference call by using the international dial-in +44 (0) 1452 542 303 and passcode 66255710. Presentation slides that provide an overview of the transaction will be made available at www.iggroup.com before the start of the conference call.
A replay of the conference call will be available for a period of 14 days after the event by dialling +44 (0) 1452 550 000 and using the passcode: 66255710.
For further information please contact:
IG Group Holdings plc 020 7896 0011
Tim Howkins, Chief Executive
Steve Clutton, Finance Director
Financial Dynamics 020 7269 7200
Robert Bailhache
Nick Henderson
UBS Investment Bank 020 7567 8000
Adrian Haxby
Tom Johnson
Lexicon Partners 020 7653 6000
Mark Hennessy
Nick Chapman
Disclaimer
UBS is acting exclusively for IG and for no one else in relation to the proposed Placing and will not regard any other person as a client in relation to the Placing and will not be responsible to any other person for providing the protections afforded to its clients nor for providing advice in connection with the Placing, or any other matters referred to in this announcement.
Lexicon Partners, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for IG in connection with the Acquisition and no-one else and will not be responsible to anyone other than IG for providing the protections afforded to their clients or for providing advice in relation to the Acquisition or any matter referred to in this announcement.
This announcement does not constitute an offer to sell or issue, or the solicitation of an offer to buy or subscribe for, Placing Shares in any jurisdiction including, without limitation, the United Kingdom, the United States, Canada, Australia or Japan. This announcement and the information contained herein is not for publication or distribution, directly or indirectly, to persons in the United States, Canada, Australia, Japan or in any jurisdiction in which such publication or distribution is unlawful.
This announcement (including the Appendix) is not an offer of securities for sale in the United States. Placing Shares may not be offered, sold or transferred in the United States absent registration under the U.S. Securities Act of 1933, as amended (the 'Securities Act') or an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Company has not offered and does not intend to offer any securities to the public in the United States.
The Placing Shares referred to in this announcement have not been and will not be registered under the Securities Act or with any securities regulatory authority of any State or other jurisdiction of the United States. Any offering to be made in the United States will be made to a limited number of qualified institutional buyers ('QIBs') pursuant to an exemption from registration under the Securities Act in a transaction not involving any public offering. The Placing Shares are being offered and sold outside the United States in accordance with Regulation S under the Securities Act.
The Placing Shares referred to in this announcement have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (the ''Financial Instruments and Exchange Law''). Accordingly, UBS will not, directly or indirectly, offer or sell any Placing Shares in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organised under the laws of Japan) or to others for re-offering or resale, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan, except pursuant to an exception from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Law and other relevant laws and regulations of Japan.
The distribution of this announcement and the Placing and/or issue of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by IG, UBS, or any of their respective Affiliates, that would permit an offer of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by IG and UBS to inform themselves about and to observe any such restrictions.
Certain statements made in this announcement constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as ''may'', ''will'', ''expect'', ''intend'', ''estimate'', ''anticipate'', ''believe'', ''plan'', ''seek'', ''continue'' or similar expressions and relate to, among other things, the performance of IG's various business units in the near to medium term, IG's expectations in respect of the Placing, IG's business strategy and its plans and objectives for future operations. Such statements are based on current expectations and, by their nature, are subject to a number of risks and uncertainties that could cause actual results and performance to differ materially from any expected future results or performance, expressed or implied, by the forward-looking statement. Factors that might cause forward-looking statements to differ materially from actual results, include among other things, general economic conditions in the European Union, in particular in the United Kingdom, and in other countries in which IG has business activities or investments, including the United States and, following the Acquisition, Japan; and the potential exposure of IG to various types of market risks, such as interest rate risk, foreign exchange rate risk, credit risk and commodity and equity price risk.
These forward-looking statements speak only as of the date of this announcement. The information and opinions contained in this announcement are subject to change without notice and, subject to compliance with applicable law, IG assumes no responsibility or obligation to update publicly or revise any of the forward-looking statements contained herein.
Any indication in this announcement of the price at which ordinary shares in IG have been bought or sold in the past cannot be relied upon as a guide to future performance. No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per share of IG for the current or future financial years would necessarily match or exceed the historical published earnings per share of IG.
This announcement is the sole responsibility of IG. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by UBS, Lexicon Partners or by any of their respective Affiliates or agents as to or in relation to, the accuracy or completeness of this announcement, or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is hereby expressly disclaimed.
APPENDIX
Further information on the Placing
IMPORTANT INFORMATION FOR PLACEES ONLY REGARDING THE PLACING
MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT, THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN, AND ANY OFFER MADE SUBSEQUENTLY, ARE DIRECTED ONLY AT PERSONS WHOSE ORDINARY ACTIVITIES INVOLVE THEM IN ACQUIRING, HOLDING, MANAGING AND DISPOSING OF INVESTMENTS (AS PRINCIPAL OR AGENT) FOR THE PURPOSES OF THEIR BUSINESS AND WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS AND ARE (1) QUALIFIED INVESTORS AS DEFINED IN SECTION 86(7) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ('FSMA'), BEING PERSONS FALLING WITHIN THE MEANING OF ARTICLE 2.1(e)(i), (ii) OR (iii) OF DIRECTIVE 2003/71/EC (THE 'PROSPECTUS DIRECTIVE') (A 'QUALIFIED INVESTOR') AND (2) IN THE UNITED KINGDOM FALL WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE 'ORDER') OR ARE PERSONS WHO FALL WITHIN ARTICLE 49(2)(a) TO (d) ('HIGH NET WORTH COMPANIES, UNINCORPORATED ASSOCIATIONS, ETC') OF THE ORDER (ALL SUCH PERSONS TOGETHER BEING REFERRED TO AS 'RELEVANT PERSONS'). THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN (AND THE ANNOUNCEMENT OF WHICH IT FORMS A PART) MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. PERSONS DISTRIBUTING THIS ANNOUNCEMENT (INCLUDING THIS APPENDIX) MUST SATISFY THEMSELVES THAT IT IS LAWFUL TO DO SO. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN RELATE IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS. THIS APPENDIX DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN GIRAFFE. THE PLACING SHARES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE 'SECURITIES ACT') OR WITH ANY REGULATORY AUTHORITY OF ANY STATE OR OTHER JURISDICTION IN THE UNITED STATES AND ARE BEING OFFERED AND SOLD IN THE UNITED STATES ONLY TO QUALIFIED INSTITUTIONAL BUYERS ('QIBs') IN A TRANSACTION NOT INVOLVING A 'PUBLIC OFFERING' WITHIN THE MEANING OF SECTION 4(2) OF THE SECURITIES ACT THAT IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND OUTSIDE THE UNITED STATES TO CERTAIN PERSONS IN OFFSHORE TRANSACTIONS IN RELIANCE ON REGULATION S UNDER THE SECURITIES ACT.
EACH PLACEE SHOULD CONSULT WITH ITS OWN ADVISERS AS TO LEGAL, TAX, BUSINESS AND RELATED ASPECTS OF A PURCHASE OF PLACING SHARES.
This announcement and any subsequent offer made is only addressed to and directed at persons in member states of the European Economic Area ('EEA') who are Qualified Investors within the meaning of Article 2(1)(e) of the Prospectus Directive or otherwise in circumstances which have not resulted and which will not result in an offer to the public in any member state in the EEA.
Persons choosing to participate in the Bookbuilding Process (as defined in this appendix) and the Placing ('Placees') will be deemed to have read and understood this appendix in its entirety (including, without limitation, the terms and conditions) and will be deemed to be making any offer to participate and to acquire Placing Shares on the terms and conditions, and to be providing the representations, warranties, acknowledgements and undertakings, contained in this appendix.
In particular each such Placee represents, warrants and acknowledges that:
1. it is a Relevant Person and undertakes that it will acquire, hold, manage or dispose of any Placing Shares that are allocated to it for the purposes of its business;
2. in the case of a Relevant Person in a member state of the EEA which has implemented the Prospectus Directive (each a 'Relevant Member State') who acquires any Placing Shares pursuant to the Placing:
(a) it is a Qualified Investor; and(b) in the case of any Placing Shares acquired by it as a financial intermediary, as that term is used in Article 3(2) of the Prospectus Directive, (i) the Placing Shares acquired by it in the Placing have not been acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in any Relevant Member State other than Qualified Investors or in circumstances in which the prior consent of UBS has been given to the offer or resale; or (ii) where Placing Shares have been acquired by it on behalf of persons in any member state of the EEA other than Qualified Investors, the offer of those Placing Shares to it is not treated under the Prospectus Directive as having been made to such persons;
3. it is acquiring the Placing Shares for its own account or is acquiring the Placing Shares for an account with respect to which it exercises sole investment discretion, and that it (and any such account) is outside the United States in reliance upon Regulation S under the Securities Act; and if it is not outside the United States, it has duly executed an investor letter in the form provided to it and delivered the same to UBS or its affiliate.
The Company, UBS and their respective Affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements.
This announcement (including this appendix) does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for Placing Shares in any jurisdiction including, without limitation, the United Kingdom, the United States, Australia, Canada or Japan. This announcement and the information contained herein is not for publication or distribution, directly or indirectly, to persons in the United States, Australia, Canada or Japan or in any jurisdiction in which such publication or distribution is unlawful.
The Placing Shares referred to in this announcement have not been and will not be registered under the Securities Act or with any securities regulatory authority of any State or other jurisdiction of the United States, and may not be offered, sold or transferred in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Any offering to be made in the United States will be made to a limited number of QIBs within the meaning of Rule 144A of the Securities Act pursuant to an exemption from registration under the Securities Act or in a transaction not involving any public offering. The Placing Shares are being offered and sold outside the United States in accordance with Regulation S under the Securities Act.
The Placing Shares referred to in this announcement have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (the ''Financial Instruments and Exchange Law''). Accordingly, UBS will not, directly or indirectly, offer or sell any Placing Shares in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organised under the laws of Japan) or to others for re-offering or resale, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan, except pursuant to an exception from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Law and other relevant laws and regulations of Japan.
The distribution of this announcement and the Placing and/or issue of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company, UBS or any of their respective Affiliates that would permit an offer of such Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company and UBS to inform themselves about and to observe any such restrictions.
In this appendix, unless the context otherwise requires, the Company means IG Group Holdings plc and Placee includes a person (including individuals, funds or others) on whose behalf a commitment to acquire Placing Shares has been given.
Details of the Placing Agreement and the Placing Shares
Pursuant to a placing agreement between UBS and the Company (the 'Placing Agreement'), UBS has, on the terms and subject to the satisfaction of certain conditions and in reliance upon the representations, warranties and undertakings given by the Company in the Placing Agreement, undertaken to use its reasonable endeavours as agent for and on behalf of the Company to seek to procure Placees for the Placing Shares and has undertaken to underwrite the Placing Shares.
The Placing Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the existing issued ordinary shares of 0.005 pence per share in the capital of the Company, with the right to receive all dividends and other distributions declared, made or paid in respect of such ordinary shares after the date of issue of the Placing Shares (excluding, for the avoidance of doubt, the final dividend for the financial year ended 31 May 2008).
Application for listing and admission to trading
Application will be made to the UK Listing Authority and to the London Stock Exchange for the Placing Shares to be admitted, respectively, to the Official List of the UK Listing Authority and to trading by the London Stock Exchange on its market for listed securities (together 'Admission'). It is expected that Admission will take place on or before 29 September 2008 and that dealings in the Placing Shares on the main market for listed securities of London Stock Exchange plc will commence at the same time.
Bookbuilding Process
Commencing today, UBS will be conducting an accelerated bookbuilding process (the 'Bookbuilding Process') to determine demand for participation in the Placing by the Placees. This appendix gives details of the terms and conditions of, and the mechanics of participation in, the Placing. No commissions will be paid to Placees or by Placees in respect of any Placing Shares.
UBS and the Company will be entitled to effect the Placing by such alternative method to the Bookbuilding Process as they may, in their sole discretion, determine.
Participation in, and principal terms of, the Bookbuilding Process
UBS is arranging the Placing as agent for and on behalf of the Company. Participation in the Placing will only be available to persons who may lawfully be, and are, invited by UBS to participate.
By participating in the Bookbuilding Process and the Placing, Placees will be deemed to have read and understood this announcement (including this appendix) in its entirety and to be participating and making an offer for Placing Shares on the terms and conditions, and to be providing the representations, warranties, acknowledgements and undertakings, contained in this appendix.
Persons who are eligible to participate in the Bookbuilding Process and the Placing should communicate their bid by telephone to their usual sales contact at UBS. Each bid should state the number of shares in the Company which a prospective Placee wishes to acquire at either the Placing Price, which is ultimately established by the Company and UBS, or at prices up to a price limit specified in its bid. Bids may be scaled down by UBS on the basis referred to below.
UBS and its Affiliates (as defined below) are entitled to participate as principal in the Bookbuilding Process.
The Bookbuilding Process will establish a single price (the 'Placing Price') payable to UBS by all Placees. The Placing Price and the aggregate proceeds to be raised through the Placing will be agreed between UBS and the Company following completion of the Bookbuilding Process and any discount to the market price of the Placing Shares will be determined in accordance with the Listing Rules. The Company will make a further announcement on a Regulatory Information Service ('RIS') following the close of the Bookbuilding Process detailing the Placing Price (the 'Pricing Announcement').
The timing of the closing of the books, pricing and allocations is at the discretion of UBS and the Company. UBS and the Company may, at their sole discretion, accept bids that are received after the Bookbuilding Process has closed. UBS and the Company reserve the right to reduce or seek to increase the amount to be raised at their sole discretion.
A bid in the Bookbuilding Process will be made on the terms and conditions in this appendix and, except with UBS's consent, will not be capable of variation or revocation after the time at which it is submitted.
To the fullest extent permissible by law, neither UBS nor any of its holding companies, subsidiaries, branches or associated undertakings or any subsidiary, branch, affiliate or associated undertaking of any such holding company nor any of their respective directors, officers or employees (each an 'Affiliate') shall have any liability to Placees (or to any other person whether acting on behalf of a Placee or otherwise). In particular, UBS and its Affiliates shall not have any liability (including, to the extent permissible by law, any fiduciary duties) in respect of its conduct of the Bookbuilding Process or of such alternative method of effecting the Placing as UBS and the Company may agree.
If successful, each Placee's allocation of Placing Shares, and the Placing Price, will be confirmed to Placees orally by UBS as soon as practicable following the close of the Bookbuilding Process and a conditional advice note will be dispatched as soon as practicable thereafter. UBS's oral confirmation to any such Placee will constitute a legally binding commitment upon such Placee, in favour of UBS and the Company, to acquire the number of Placing Shares allocated to it at the Placing Price on the terms and conditions set out in this appendix and in accordance with the Company's Memorandum and Articles of Association.
Each Placee will have an immediate, separate, irrevocable and binding obligation, owed to UBS, to pay to it (or as it may direct) in cleared funds an amount equal to the product of the Placing Price and the number of Placing Shares such Placee has agreed to acquire.
All obligations under the Placing will be subject to the fulfilment of the conditions referred to below under 'Conditions of the Placing' and to the Placing not being terminated on the basis referred to below under 'Right to terminate under the Placing Agreement'.
Conditions of the Placing
The Placing is conditional upon the Placing Agreement becoming unconditional and not having been terminated in accordance with its terms.
UBS's obligations under the Placing Agreement are, and the Placing is, conditional on, inter alia:
If the conditions in the Placing Agreement are not satisfied or waived in accordance with the Placing Agreement within the stated time periods (or such later time and/or date as the Company and UBS may agree), or the Placing Agreement is terminated in accordance with its terms, the Placing will lapse and the Placees' rights and obligations shall cease and terminate at such time and each Placee agrees that no claim can be made by or on behalf of the Placee (or any person on whose behalf the placee is acting) in respect thereof.
By participating in the Bookbuilding Process, each Placee agrees that its rights and obligations cease and terminate only in the circumstances described above and under 'Right to terminate under the Placing Agreement' below and will not be capable of rescission or termination by it after oral confirmation from UBS following the close of the Bookbuilding Process.
UBS may, in its absolute discretion and upon such terms as it thinks fit, waive compliance or extend the time and/or date for fulfilment by the Company with the whole or any part of certain of the Company's obligations in relation to the conditions in the Placing Agreement. Any such extension or waiver will not affect Placees' commitments as set out in this appendix.
None of UBS, the Company or any of their respective Affiliates shall have any liability to any Placee (or to any other person whether acting on behalf of a Placee or otherwise) in respect of any decision any of them may make as to whether or not to waive or to extend the time and/or date for the satisfaction of any condition to the Placing nor for any decision any of them may make as to the satisfaction of any condition or in respect of the Placing generally.
Right to terminate under the Placing Agreement
UBS may, in its absolute discretion, by notice given to the Company terminate the Placing Agreement at any time prior to Admission if, inter alia:
If the Placing Agreement is terminated in accordance with its terms, the rights and obligations of each Placee in respect of the Placing as described in this announcement (including this appendix) shall cease and terminate at such time and no claim can be made by any Placee in respect thereof.
By participating in the Placing, each Placee agrees with the Company and UBS that the exercise by the Company or UBS of any right of termination or any other right or other discretion under the Placing Agreement shall be within the absolute discretion of the Company or UBS (as the case may be) and that neither the Company nor UBS need make any reference to such Placee and that neither the Company, nor UBS nor any of their Affiliates shall have any liability to such Placee (or to any other person whether acting on behalf of a Placee or otherwise) whatsoever in connection with any such exercise.
No Prospectus
No prospectus or other offering document has been or will be submitted to be approved by the FSA, or by the competent authority in any other jurisdiction, in relation to the Placing and Placees' commitments will be made solely on the basis of the information contained in this announcement (including this appendix) and the Pricing Announcement. Each Placee, by participating in the Bookbuilding Process and, if relevant, the Placing, confirms that it has neither received nor relied on any information, representation, warranty or statement made by or on behalf of UBS or the Company other than the content of this announcement (including this appendix) and the Pricing Announcement and neither UBS nor the Company nor any person acting on such person's behalf nor any of their holding companies, subsidiaries, branches, affiliates or associated undertakings or any subsidiary, branch, affiliate or associated undertaking of any such holding company nor any of their respective directors, officers or employees, has or shall have any liability for any Placee's decision to participate in the Bookbuilding Process and, if relevant, the Placing, based on any other information, representation, warranty or statement including (but not limited to) any publicly available or filed information. Each Placee acknowledges, agrees and warrants that it has relied on its own investigation of the business, financial or other position of the Company in deciding whether to participate in the Bookbuilding Process and, if relevant, the Placing. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation.
Registration and Settlement
Settlement of transactions in the Placing Shares following Admission will take place within the CREST system, subject to certain exceptions. UBS and the Company reserve the right to require settlement for, and delivery to Placees of, the Placing Shares by such other means as they deem necessary if delivery or settlement is not practicable within the CREST system within the timetable set out in this announcement and appendix or would not be consistent with the regulatory requirements in any Placee's jurisdiction.
Each Placee allocated Placing Shares in the Placing will be sent a conditional advice note stating the number of Placing Shares allocated to it, the Placing Price and the aggregate amount owed by such Placee to UBS. In agreeing to acquire the number of Placing Shares set out in the conditional advice note, such Placee agrees that it will do all things necessary to ensure that delivery and payment is completed in accordance with either the standing CREST instructions or the certificated settlement instructions which it has in place with UBS.
Settlement through CREST will be on a T+3 basis unless otherwise notified by UBS.
Interest is chargeable daily on payments not received from Placees on the due date in accordance with the arrangements set out above at the rate of 2 percentage points above prevailing LIBOR as determined by UBS.
Each Placee is deemed to agree that if it does not comply with these obligations, UBS may sell any or all of the Placing Shares allocated to it on such Placee's behalf and retain from the proceeds, for UBS's own account and benefit, an amount equal to the aggregate amount owed by the Placee plus any interest due. The relevant Placee will, however, remain liable for any shortfall below the aggregate amount owed by it and for any stamp duty or stamp duty reserve tax (together with any interest or penalties) which may arise upon the sale of such Placing Shares on such Placee's behalf.
Insofar as Placing Shares are registered in a Placee's name or that of its nominee or in the name of any person for whom a Placee is contracting as agent or that of a nominee for such person, such Placing Shares should, subject as provided below, be so registered free from any liability to UK stamp duty or stamp duty reserve tax. No participant will be entitled to receive any fee or commission in connection with the Placing.
If Placing Shares are to be delivered to a custodian or settlement agent, Placees should ensure that the conditional advice note is copied and delivered immediately to the relevant person within that organisation.
Representations and warranties
By participating in the Bookbuilding Process and the Placing each Placee (and any person acting on such Placee's behalf) represents, warrants, acknowledges and agrees (for itself and for any such respective Placee) that:
Any arrangements to issue or transfer the Placing Shares into a depositary receipts system or a clearance service or to hold the Placing Shares as agent or nominee of a person to whom a depositary receipt may be issued or who will hold the Placing Shares in a clearance service, or any arrangements subsequently to transfer the Placing Shares, may give rise to UK stamp duty and/or stamp duty reserve tax, for which neither the Company nor UBS will be responsible and the Placee to whom (or on behalf of whom, or in respect of the person for whom it is participating in the Placing as an agent or nominee) the allocation, allotment, issue or delivery of Placing Shares has given rise to such UK stamp duty or stamp duty reserve tax undertakes to pay such UK stamp duty or stamp duty reserve tax forthwith and to indemnify on an after-tax basis and to hold harmless the Company and UBS in the event that either the Company or UBS has incurred any such liability to UK stamp duty or stamp duty reserve tax.
Stamp, registration, documentary, transfer and similar taxes or duties payable outside the UK will be the responsibility of the relevant Placee and the Placee, or the Placee's nominee, in respect of whom (or in respect of the person for whom it is participating in the Placing as an agent or nominee) the allocation, allotment, issue or delivery of Placing Shares has given rise to such non-UK stamp, registration, documentary, transfer or similar taxes or duties undertakes to pay such taxes and duties forthwith and to indemnify on an after-tax basis and to hold harmless the Company and UBS in the event that either the Company or UBS has incurred any such liability to such taxes or duties.
This announcement has been issued by the Company and is the sole responsibility of the Company.
UBS is acting for the Company and no-one else in connection with the Placing and other matters referred to in this announcement, and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to the Placing or any other matter referred to in this announcement.
When a Placee or person acting on behalf of the Placee is dealing with UBS, any money held in an account with UBS on behalf of the Placee and/or any person acting on behalf of the Placee will not be treated as client money (within the meaning of the rules and regulations of the FSA made under FSMA) which, therefore, will not require UBS to segregate such money, as that money will be held by it under a banking relationship and not as a trustee.
Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. Each Placee and each person acting on behalf of the Placee acknowledges that neither UBS, nor any of its Affiliates, is making any recommendations to it, advising it regarding the suitability of any transactions it may enter into in connection with the Placing nor providing advice in relation to the Placing nor in respect of any warranties, representations, undertakings or indemnities contained in the Placing Agreement nor the exercise or performance of any of UBS' rights and obligations thereunder including any rights to waive or vary any conditions or exercise any termination rights.
All times and dates in this announcement may be subject to amendment. UBS shall notify the Placees and any person acting on behalf of the Placees of any changes.
Definitions
In this announcement, unless the context otherwise requires:
'Closing Date' means the date to be agreed between UBS and the Company, expected to be the date three business days from the date of this announcement;
'FSA' means the Financial Services Authority acting in its capacity as the competent authority for the purposes of Part VI of FSMA and in the exercise of its functions in respect of the admission of securities to the Official List otherwise than in accordance with Part VI of FSMA;
'Listing Rules' means the listing rules produced by the FSA under Part VI of FSMA and forming part of the FSA's Handbook of rules and guidance, as amended from time to time;
'Placing' means the placing of the Placing Shares by UBS on behalf of the Company pursuant to the provisions of the Placing Agreement;
'Regulation S' means Regulation S promulgated under the Securities Act;
'UBS' or 'UBS Investment Bank' means UBS Limited, a company registered in England and Wales whose registered office is 1 Finsbury Avenue, London EC2M 2PP;
'United Kingdom' or 'UK' means the United Kingdom of Great Britain and Northern Ireland; and
'United States' means the United States of America, its territories and possessions, any State of the United States and the District of Columbia.